Abstract
Myocardial infarction, or heart attack, is a principal cause of congestive heart failure and adult morbidity and mortality in the western world. Since the adult myocardium lacks the inherent ability to repair itself following ischemic injury, a number of exogenous cell sources with differing cardiomyogenic potential have been investigated for the restoration of infarcted myocardium. To this end, the ability of embryonic-stem-cell-derived cardiomyocytes (ESC-CMs) to successfully engraft within host myocardium, fully differentiate to a mature cardiomyogenic phenotype, and electromechanically couple with host cardiomyocytes upon transplantation has been a subject of much inquiry in recent years. Overall, these studies demonstrate that the use of ESC-CMs alone or in conjunction with a biodegradable scaffold serves as a novel route to restore cardiomyocytes to the heart and thereby facilitate myocardial repair and functional regeneration.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Heart Disease and Stroke Statistics – 2005 Update. 2005, American Heart Association: Dallas, TX.
Rosenthal, N. and A. Musaro, Gene therapy for cardiac cachexia? Int J Cardiol, 2002. 85(1): p. 185–91.
Fujimoto, K.L., et al., An elastic, biodegradable cardiac patch induces contractile smooth muscle and improves cardiac remodeling and function in subacute myocardial infarction. J Am Coll Cardiol, 2007. 49(23): p. 2292–300.
Gnecchi, M., et al., Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med, 2005. 11(4): p. 367–8.
Ott, H.C., J. McCue, and D.A. Taylor, Cell-based cardiovascular repair – the hurdles and the opportunities. Basic Res Cardiol, 2005. 100(6): p. 504–17.
Lietz, K. and L.W. Miller, Will left-ventricular assist device therapy replace heart transplantation in the foreseeable future? Curr Opin Cardiol, 2005. 20(2): p. 132–7.
Taylor, D.A., Cell-based myocardial repair: how should we proceed? Int J Cardiol, 2004. 95 Suppl 1: p. S8–12.
Chachques, J.C., et al., Myocardial assistance by grafting a new bioartificial upgraded myocardium (MAGNUM trial): clinical feasibility study. Ann Thorac Surg, 2008. 85(3): p. 901–8.
de la Fuente, L.M., et al., Transendocardial autologous bone marrow in chronic myocardial infarction using a helical needle catheter: 1-year follow-up in an open-label, nonrandomized, single-center pilot study (the TABMMI study). Am Heart J, 2007. 154(1): p. 79.e1–7.
Lunde, K., et al., Autologous stem cell transplantation in acute myocardial infarction: the ASTAMI randomized controlled trial. Intracoronary transplantation of autologous mononuclear bone marrow cells, study design and safety aspects. Scand Cardiovasc J, 2005. 39(3): p. 150–8.
Lunde, K., et al., Exercise capacity and quality of life after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: results from the autologous stem cell transplantation in acute myocardial infarction (ASTAMI) randomized controlled trial. Am Heart J, 2007. 154(4): p. 710.e1–8.
Ripa, R.S., et al., Bone marrow derived mesenchymal cell mobilization by granulocyte-colony stimulaWting factor after acute myocardial infarction: results from the Stem Cells in Myocardial Infarction (STEMMI) trial. Circulation, 2007. 116(11 Suppl): p. I24–30.
Schachinger, V., et al., Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI trial. J Am Coll Cardiol, 2004. 44(8): p. 1690–9.
Wollert, K.C., et al., Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet, 2004. 364(9429): p. 141–8.
Hamdi, H., et al., Cell delivery: intramyocardial injections or epicardial deposition? A head-to-head comparison. Ann Thorac Surg, 2009. 87(4): p. 1196–203.
Moscoso, I., et al., Analysis of different routes of administration of heterologous 5-azacytidine-treated mesenchymal stem cells in a porcine model of myocardial infarction. Transplant Proc, 2009. 41(6): p. 2273–5.
Alperin, C., P.W. Zandstra, and K.A. Woodhouse, Polyurethane films seeded with embryonic stem cell-derived cardiomyocytes for use in cardiac tissue engineering applications. Biomaterials, 2005. 26(35): p. 7377–86.
Shimko, V.F. and W.C. Claycomb, Effect of mechanical loading on three-dimensional cultures of embryonic stem cell-derived cardiomyocytes. Tissue Eng Part A, 2008. 14(1): p. 49–58.
Wang, X., et al., Scalable producing embryoid bodies by rotary cell culture system and constructing engineered cardiac tissue with ES-derived cardiomyocytes in vitro. Biotechnol Prog, 2006. 22(3): p. 811–8.
Singla, D.K. and B.E. Sobel, Enhancement by growth factors of cardiac myocyte differentiation from embryonic stem cells: a promising foundation for cardiac regeneration. Biochem Biophys Res Commun, 2005. 335(3): p. 637–42.
Caspi, O., et al., Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J Am Coll Cardiol, 2007. 50(19): p. 1884–93.
Singla, D.K., et al., Transplantation of embryonic stem cells into the infarcted mouse heart: formation of multiple cell types. J Mol Cell Cardiol, 2006. 40(1): p. 195–200.
Kehat, I., et al., Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest, 2001. 108(3): p. 407–14.
Sargent, C., G. Berguig, and T. McDevitt, Cardiomyogenic differentiation of embryoid bodies is promoted by rotary orbital suspension culture. Tissue Engineering Part A, 2009. 15(2): p. 331–32.
Wei, H., et al., Embryonic stem cells and cardiomyocyte differentiation: phenotypic and molecular analyses. J Cell Mol Med, 2005. 9(4): p. 804–17.
Dai, W., et al., Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat hearts. J Mol Cell Cardiol, 2007. 43(4): p. 504–16.
Chen, Y., et al., Cyclic adenosine 3′,5′-monophosphate induces differentiation of mouse embryonic stem cells into cardiomyocytes. Cell Biol Int, 2006. 30(4): p. 301–7.
Paquin, J., et al., Oxytocin induces differentiation of P19 embryonic stem cells to cardiomyocytes. Proc Natl Acad Sci USA, 2002. 99(14): p. 9550–5.
Hatami, L., M.R. Valojerdi, and S.J. Mowla, Effects of oxytocin on cardiomyocyte differentiation from mouse embryonic stem cells. Int J Cardiol, 2007. 117(1): p. 80–9.
Bugorsky, R., J.C. Perriard, and G. Vassalli, N-cadherin is essential for retinoic acid-mediated cardiomyogenic differentiation in mouse embryonic stem cells. Eur J Histochem, 2007. 51(3): p. 181–92.
Niebruegge, S., et al., Cardiomyocyte production in mass suspension culture: embryonic stem cells as a source for great amounts of functional cardiomyocytes. Tissue Eng Part A, 2008. 14(10): p. 1591–601.
Roggia, C., et al., Hepatocyte growth factor (HGF) enhances cardiac commitment of differentiating embryonic stem cells by activating PI3 kinase. Exp Cell Res, 2007. 313(5): p. 921–30.
Wang, Z., et al., Neuregulin-1 enhances differentiation of cardiomyocytes from embryonic stem cells. Med Biol Eng Comput, 2009. 47(1): p. 41–8.
Khezri, S., et al., Effect of basic fibroblast growth factor on cardiomyocyte differentiation from mouse embryonic stem cells. Saudi Med J, 2007. 28(2): p. 181–6.
Singla, D.K. and B. Sun, Transforming growth factor-beta2 enhances differentiation of cardiac myocytes from embryonic stem cells. Biochem Biophys Res Commun, 2005. 332(1): p. 135–41.
Laflamme, M.A., et al., Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol, 2007. 25(9): p. 1015–24.
Rajasingh, J., et al., STAT3-dependent mouse embryonic stem cell differentiation into cardiomyocytes: analysis of molecular signaling and therapeutic efficacy of cardiomyocyte precommitted mES transplantation in a mouse model of myocardial infarction. Circ Res, 2007. 101(9): p. 910–8.
Sachinidis, A., et al., Identification of platelet-derived growth factor-BB as cardiogenesis-inducing factor in mouse embryonic stem cells under serum-free conditions. Cell Physiol Biochem, 2003. 13(6): p. 423–9.
Graichen, R., et al., Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPK. Differentiation, 2008. 76(4): p. 357–70.
Mummery, C., et al., Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation, 2003. 107(21): p. 2733–40.
Xu, X.Q., et al., Chemically defined medium supporting cardiomyocyte differentiation of human embryonic stem cells. Differentiation, 2008. 76(9): p. 958–70.
Singla, D.K., Embryonic stem cells in cardiac repair and regeneration. Antioxid Redox Signal, 2009. 11(8): p. 1857–63.
Doss, M.X., et al., Global transcriptome analysis of murine embryonic stem cell-derived cardiomyocytes. Genome Biol, 2007. 8(4): p. R56.
Klug, M.G., et al., Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts. J Clin Invest, 1996. 98(1): p. 216–24.
Bugorsky, R., J.C. Perriard, and G. Vassalli, Genetic selection system allowing monitoring of myofibrillogenesis in living cardiomyocytes derived from mouse embryonic stem cells. Eur J Histochem, 2008. 52(1): p. 1–10.
Zandstra, P.W., et al., Scalable production of embryonic stem cell-derived cardiomyocytes. Tissue Eng, 2003. 9(4): p. 767–78.
Muller, M., et al., Selection of ventricular-like cardiomyocytes from ES cells in vitro. FASEB J, 2000. 14(15): p. 2540–8.
Moretti, A., et al., Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell, 2006. 127(6): p. 1151–65.
Bu, L., et al., Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature, 2009. 460(7251): p. 113–7.
Xu, C., et al., Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res, 2002. 91(6): p. 501–8.
Xu, C., et al., Cardiac bodies: a novel culture method for enrichment of cardiomyocytes derived from human embryonic stem cells. Stem Cells Dev, 2006. 15(5): p. 631–9.
Min, J.Y., et al., Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. J Appl Physiol, 2002. 92(1): p. 288–96.
Menard, C., et al., Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study. Lancet, 2005. 366(9490): p. 1005–12.
Laflamme, M.A., et al., Formation of human myocardium in the rat heart from human embryonic stem cells. Am J Pathol, 2005. 167(3): p. 663–71.
Kofidis, T., et al., Allopurinol/uricase and ibuprofen enhance engraftment of cardiomyocyte-enriched human embryonic stem cells and improve cardiac function following myocardial injury. Eur J Cardiothorac Surg, 2006. 29(1): p. 50–5.
van Laake, L.W., et al., Human embryonic stem cell-derived cardiomyocytes and cardiac repair in rodents. Circ Res, 2008. 102(9): p. 1008–10.
van Laake, L.W., et al., Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Res, 2007. 1(1): p. 9–24.
van Laake, L.W., et al., Improvement of mouse cardiac function by hESC-derived cardiomyocytes correlates with vascularity but not graft size. Stem Cell Res, 2009. 3(2–3): p. 106–12.
van Laake, L.W., et al., Extracellular matrix formation after transplantation of human embryonic stem cell-derived cardiomyocytes. Cell Mol Life Sci, 2010. 67(2): p. 277–90
Stevens, K.R., et al., Scaffold-free human cardiac tissue patch created from embryonic stem cells. Tissue Eng Part A, 2009. 15(6): p. 1211–22.
Stevens, K.R., et al., Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue. Proc Natl Acad Sci USA, 2009. 106(39): p. 16568–73.
Nussbaum, J., et al., Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J, 2007. 21(7): p. 1345–57.
McDevitt, T.C., et al., Spatially organized layers of cardiomyocytes on biodegradable polyurethane films for myocardial repair. J Biomed Mater Res A, 2003. 66(3): p. 586–95.
Fromstein, J.D., et al., Seeding bioreactor-produced embryonic stem cell-derived cardiomyocytes on different porous, degradable, polyurethane scaffolds reveals the effect of scaffold architecture on cell morphology. Tissue Eng Part A, 2008. 14(3): p. 369–78.
Guo, X.M., et al., Creation of engineered cardiac tissue in vitro from mouse embryonic stem cells. Circulation, 2006. 113(18): p. 2229–37.
Shapira-Schweitzer, K., et al., A photopolymerizable hydrogel for 3-D culture of human embryonic stem cell-derived cardiomyocytes and rat neonatal cardiac cells. J Mol Cell Cardiol, 2009. 46(2): p. 213–24.
Kofidis, T., et al., Novel injectable bioartificial tissue facilitates targeted, less invasive, large-scale tissue restoration on the beating heart after myocardial injury. Circulation, 2005. 112(9 Suppl): p. I173–7.
Ke, Q., et al., Embryonic stem cells cultured in biodegradable scaffold repair infarcted myocardium in mice. Sheng Li Xue Bao, 2005. 57(6): p. 673–81.
Baraniak, P.R. and T.C. McDevitt, Stem cell paracrine actions and tissue regeneration. Regen Med, 2010. 5(1): p. 121–43.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Baraniak, P.R., McDevitt, T.C. (2011). Regenerating Function In Vivo with Myocytes Derived from Embryonic Stem Cells. In: Cohen, I., Gaudette, G. (eds) Regenerating the Heart. Stem Cell Biology and Regenerative Medicine. Humana Press. https://doi.org/10.1007/978-1-61779-021-8_3
Download citation
DOI: https://doi.org/10.1007/978-1-61779-021-8_3
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-020-1
Online ISBN: 978-1-61779-021-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)